Mouse models of growth hormone action and aging: A proteomic perspective

Proteomics

Volumn 13, Issue 3-4, 2013, Pages 674-685

  Ding, Juan ^a   Sackmann Sala, Lucila ^b   Kopchick, John J ^c  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b INSERM   (France)

^c OHIO UNIVERSITY   (United States)

Author keywords

2DE; Aging; Animal proteomics; Growth hormone; Proteomics

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; CHOLESTEROL; FATTY ACID; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMA PROTEIN; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ACROMEGALY; ADIPOCYTE; AGING; BODY COMPOSITION; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; FAT MASS; FATTY ACID BLOOD LEVEL; GENE MUTATION; GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEPATITIS; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS ADENOMA; INCIDENCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LIFESPAN; LIPID ANALYSIS; LIPID METABOLISM; LIPOLYSIS; METABOLIC REGULATION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PLASMA; PREMATURE AGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; AGING; ANIMALS; BLOOD PROTEINS; GENE KNOCKOUT TECHNIQUES; GROWTH HORMONE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LIPID METABOLISM; PROTEOME; PROTEOMICS; RECEPTORS, SOMATOTROPIN;

ANIMALIA; CAENORHABDITIS ELEGANS; MUS; MUS MUSCULUS;

EID: 84873995754     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200271     Document Type: Review

References (90)

1. Holzenberger, M., The GH/IGF-I axis and longevity 10.1530/eje.0.151S023. Eur. J. Endocrinol. 2004, 151, S23-S27.
2. Berryman, D. E., List, E. O., Coschigano, K. T., Behar, K. et al., Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm. IGF Res. 2004, 14, 309-318.
3. Zhou, Y., Xu, B. C., Maheshwari, H. G., He, L. et al., A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc. Natl. Acad. Sci. USA 1997, 94, 13215-13220.
4. Laron, Z., Kopchick, J., Laron Syndrome - From Man to Mouse, Springer-Verlag, Berlin, Heidelberg, 2011.
5. Houssay, B. A., The hypophysis and metabolism. N. Engl. J. Med. 1936, 214, 961-971.
6. Rabinowitz, D., Klassen, G. A., Zierler, K. L., Effect of human growth hormone on muscle and adipose tissue metabolism in the forearm of man. J. Clin. Invest. 1965, 44, 51-61.
7. Valera, A., Rodriguez-Gil, J. E., Yun, J. S., McGrane, M. M. et al., Glucose metabolism in transgenic mice containing a chimeric P-enolpyruvate carboxykinase/bovine growth hormone gene. FASEB J. 1993, 7, 791-800.
8. Dominici, F. P., Cifone, D., Bartke, A., Turyn, D., Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice. Am. J. Physiol. Endocrinol. Metab. 1999, 277, E447-E454.
9. Dominici, F. P., Cifone, D., Bartke, A., Turyn, D., Loss of sensitivity to insulin at early events of the insulin signaling pathway in the liver of growth hormone-transgenic mice. J. Endocrinol. 1999, 161, 383-392.
10. Frick, F., Bohlooly-Y, M., Linden, D., Olsson, B. et al., Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice. AJP Endocrinol. Metabol. 2001, 281, E1230-E1239.
11. Olsson, B., Bohlooly-Y, M., Brusehed, O., Isaksson, O. G. P. et al., Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes. Am. J. Physiol. Endocrinol. Metab. 2003, 285, E504-E511.
12. Bartke, A., Peluso, M. R., Moretz, N., Wright, C. et al., Effects of soy-derived diets on plasma and liver lipids, glucose tolerance, and longevity in normal, long-lived and short-lived mice. Horm. Metab. Res. 2004, 36, 550-558.
13. Olsson, B., Bohlooly-Y, M., Fitzgerald, S. M., Frick, F. et al., Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet. Endocrinology 2005, 146, 920-930.
14. Berryman, D. E., List, E. O., Kohn, D. T., Coschigano, K. T. et al., Effect of growth hormone on susceptibility to diet-induced obesity. Endocrinology 2006, 147, 2801-2808.
15. Wang, Z., Masternak, M. M., Al-Regaiey, K. A., Bartke, A., Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. Endocrinology 2007, 148, 2845-2853.
16. Boparai, R. K., Arum, O., Khardori, R., Bartke, A., Glucose homeostasis and insulin sensitivity in growth hormone-transgenic mice: a cross-sectional analysis. Biol. Chem. 2010, 391, 1149-1155.
17. Parsons, J. A., Bartke, A., Sorenson, R. L., Number and size of islets of Langerhans in pregnant, human growth hormone-expressing transgenic, and pituitary dwarf mice: effect of lactogenic hormones. Endocrinology 1995, 136, 2013-2021.
18. del Rincon, J.-P., Iida, K., Gaylinn, B. D., McCurdy, C. E. et al., Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue. Diabetes 2007, 56, 1638-1646.
19. Palmer, A. J., Chung, M. Y., List, E. O., Walker, J. et al., Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology 2009, 150, 1353-1360.
20. Berryman, D. E., List, E. O., Sackmann-Sala, L., Lubbers, E. et al., Growth hormone and adipose tissue: beyond the adipocyte. Growth Horm. IGF Res. 2011, 21, 113-123.
21. McGrane, M. M., de Vente, J., Yun, J., Bloom, J. et al., Tissue-specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic mice. J. Biol. Chem. 1988, 263, 11443-11451.
22. Steger, R. W., Bartke, A., Cecim, M., Premature ageing in transgenic mice expressing different growth hormone genes. J. Reprod. Fertil. Suppl. 1993, 46, 61-75.
23. O'Shea, M. H., Layish, D. T., Growth hormone and the kidney: a case presentation and review of the literature. J. Am. Soc. Nephrol. 1992, 3, 157-161.
24. Colao, A., Marzullo, P., Di Somma, C., Lombardi, G., Growth hormone and the heart. Clin. Endocrinol. (Oxf). 2001, 54, 137-154.
25. Doi, T., Striker, L. J., Quaife, C., Conti, F. G. et al., Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am. J. Pathol. 1988, 131, 398-403.
26. Bielohuby, M., Roemmler, J., Manolopoulou, J., Johnsen, I. et al., Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice. Proc. Soc. Exp. Biol. Med. 2009, 234, 1002-1009.
27. Bogazzi, F., Russo, D., Raggi, F., Ultimieri, F. et al., Transgenic mice overexpressing growth hormone (GH) have reduced or increased cardiac apoptosis through activation of multiple GH-dependent or -independent cell death pathways. Endocrinology 2008, 149, 5758-5769.
28. Bogazzi, F., Raggi, F., Ultimieri, F., Russo, D. et al., Regulation of cardiac fatty acids metabolism in transgenic mice overexpressing bovine GH. J. Endocrinol. 2009, 201, 419-427.
29. Snibson, K. J., Bhathal, P. S., Hardy, C. L., Brandon, M. R. et al., High, persistent hepatocellular proliferation and apoptosis precede hepatocarcinogenesis in growth hormone transgenic mice. Liver 1999, 19, 242-252.
30. Snibson, K. J., Bhathal, P. S., Adams, T. E., Overexpressed growth hormone (GH) synergistically promotes carcinogen-initiated liver tumour growth by promoting cellular proliferation in emerging hepatocellular neoplasms in female and male GH-transgenic mice. Liver 2001, 21, 149-158.
31. Hardy, C. L., Bhathal, P. S., Snibson, K. J., Adams, T. E., Comparison of intrahepatic lymphocytes from normal and growth hormone transgenic mice with chronic hepatitis and liver cancer. Immunology 1997, 90, 412-420.
32. Doi, S. Q., Jacot, T. A., Sellitti, D. F., Hirszel, P. et al., Growth hormone increases inducible nitric oxide synthase expression in mesangial cells. J. Am. Soc. Nephrol. 2000, 11, 1419-1425.
33. Hauck, S. J., Bartke, A., Free radical defenses in the liver and kidney of human growth hormone transgenic mice: possible mechanisms of early mortality. J. Gerontol. A. Biol. Sci. Med. Sci. 2001, 56, B153-B162.
34. Andersson, I. J., Johansson, M. E., Wickman, A., Bohlooly, Y. M. et al., Endothelial dysfunction in growth hormone transgenic mice. Clin Sci. (Lond). 2006, 110, 217-225.
35. List, E. O., Sackmann-Sala, L., Berryman, D. E., Funk, K. et al., Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse. Endocr. Rev. 2011, 32, 356-386.
36. Dominici, F. P., Arostegui Diaz, G., Bartke, A., Kopchick, J. J. et al., Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice. J. Endocrinol. 2000, 166, 579-590.
37. Hauck, S. J., Hunter, W. S., Danilovich, N., Kopchick, J. J. et al., Reduced levels of thyroid hormones, insulin, and glucose, and lower body core temperature in the growth hormone receptor/binding protein knockout mouse. Exp. Biol. Med. (Maywood) 2001, 226, 552-558.
38. Coschigano, K. T., Holland, A. N., Riders, M. E., List, E. O. et al., Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I Levels and increased life span. Endocrinology 2003, 144, 3799-3810.
39. Liu, J. L., Coschigano, K. T., Robertson, K., Lipsett, M. et al., Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am. J. Physiol. Endocrinol. Metab. 2004, 287, E405-E413.
40. Guo, Y., Lu, Y., Houle, D., Robertson, K. et al., Pancreatic islet-specific expression of an insulin-like growth factor-I transgene compensates islet cell growth in growth hormone receptor gene-deficient mice. Endocrinology 2005, 146, 2602-2609.
41. Al-Regaiey, K. A., Masternak, M. M., Bonkowski, M., Sun, L. et al., Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction. Endocrinology 2005, 146, 851-860.
42. Egecioglu, E., Bjursell, M., Ljungberg, A., Dickson, S. L. et al., Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity and hypolipidemia in mice. Am. J. Physiol. Endocrinol. Metab. 2005, 292, E1418-E1425.
43. Bonkowski, M. S., Dominici, F. P., Arum, O., Rocha, J. S. et al., Disruption of growth hormone receptor prevents calorie restriction from improving insulin action and longevity. PLoS One 2009, 4, e4567.
44. Robertson, K., Kopchick, J. J., Liu, J. L., Growth hormone receptor gene deficiency causes delayed insulin responsiveness in skeletal muscles without affecting compensatory islet cell overgrowth in obese mice. Am. J. Physiol. Endocrinol. Metab. 2006, 291, E491-E498.
45. Masternak, M. M., Al-Regaiey, K. A., Del Rosario Lim, M. M., Jimenez-Ortega, V. et al., Caloric restriction and growth hormone receptor knockout: effects on expression of genes involved in insulin action in the heart. Exp. Gerontol. 2006, 41, 417-429.
46. Al-Regaiey, K. A., Masternak, M. M., Bonkowski, M. S., Panici, J. A. et al., Effects of caloric restriction and growth hormone resistance on insulin-related intermediates in the skeletal muscle. J. Gerontol. A. Biol. Sci. Med. Sci. 2007, 62, 18-26.
47. Giani, J. F., Bonkowski, M. S., Munoz, M. C., Masternak, M. M. et al., Insulin signaling cascade in the hearts of long-lived growth hormone receptor knockout mice: effects of calorie restriction. J. Gerontol. A. Biol. Sci. Med. Sci. 2008, 63, 788-797.
48. Masternak, M. M., Al-Regaiey, K. A., Del Rosario Lim, M. M., Bonkowski, M. S. et al., Caloric restriction results in decreased expression of peroxisome proliferator-activated receptor superfamily in muscle of normal and long-lived growth hormone receptor/binding protein knockout mice. J. Gerontol. A. Biol. Sci. Med. Sci. 2005, 60, 1238-1245.
49. Miller, R. A., Chang, Y., Galecki, A. T., Al-Regaiey, K. et al., Gene expression patterns in calorically restricted mice: partial overlap with long-lived mutant mice. Mol. Endocrinol. 2002, 16, 2657-2666.
50. Shimokawa, I., Chiba, T., Yamaza, H., Komatsu, T., Longevity genes: insights from calorie restriction and genetic longevity models. Mol. Cells 2008, 26, 427-435.
51. Ikeno, Y., Hubbard, G. B., Lee, S., Cortez, L. A. et al., Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. J. Gerontol. A. Biol. Sci. Med. Sci. 2009, 64, 522-529.
52. Bellush, L. L., Doublier, S., Holland, A. N., Striker, L. J. et al., Protection against diabetes-induced nephropathy in growth hormone receptor/binding protein gene-disrupted mice. Endocrinology 2000, 141, 163-168.
53. Guevara-Aguirre, J., Balasubramanian, P., Guevara-Aguirre, M., Wei, M. et al., Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Translat. Med. 2011, 3, 70ra13.
54. Steuerman, R., Shevah, O., Laron, Z., Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies. Eur. J. Endocrinol. 2011, 164, 485-489.
55. Ding, J., Berryman, D. E., Kopchick, J. J., Plasma proteomic profiles of bovine growth hormone transgenic mice as they age. Transgenic Res. 2011, 20, 1305-1320.
56. Ding, J., Berryman, D. E., Jara, A., Kopchick, J. J., Age- and sex-associated plasma proteomic changes in growth hormone receptor gene-disrupted mice. J. Gerontol. A. Biol. Sci. Med. Sci. 2011, 67, 830-840.
57. Kopchick, J. J., List, E. O., Kohn, D. T., Keidan, G. M. et al., Perspective: proteomics-see "spots" run. Endocrinology 2002, 143, 1990-1994.
58. Ding, J., List, E. O., Okada, S., Kopchick, J. J., Perspective: proteomic approach to detect biomarkers of human growth hormone. Growth Horm. IGF Res. 2009, 19, 399-407.
59. Ding, J., Kopchick, J. J., Plasma biomarkers of mouse aging. Age (Dordr) 2011, 33, 291-307.
60. Yang, Q., Graham, T. E., Mody, N., Preitner, F. et al., Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436, 356-362.
61. Kloting, N., Graham, T. E., Berndt, J., Kralisch, S. et al., Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab. 2007, 6, 79-87.
62. Ost, A., Danielsson, A., Liden, M., Eriksson, U. et al., Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes. FASEB J. 2007, 21, 3696-3704.
63. Norseen, J., Hosooka, T., Hammarstedt, A., Yore, M. M. et al., Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism. Mol. Cell. Biol. 2012, 32, 2010-2019.
64. Rosell, M., Hondares, E., Iwamoto, S., Gonzalez, F. J. et al., Peroxisome proliferator-activated receptors-alpha and -gamma, and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissue. Endocrinology 2012, 153, 1162-1173.
65. Ferrucci, L., Corsi, A., Lauretani, F., Bandinelli, S. et al., The origins of age-related proinflammatory state. Blood 2005, 105, 2294-2299.
66. Gonzalo, J. A., Mazuchelli, R., Mellado, M., Frade, J. M. et al., Enterotoxin septic shock protection and deficient T helper 2 cytokine production in growth hormone transgenic mice. J. Immunol. 1996, 157, 3298-3304.
67. Ogueta, S., Olazabal, I., Santos, I., Delgado-Baeza, E. et al., Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies. J. Endocrinol. 2000, 165, 321-328.
68. Cosentino, S., Scarmeas, N., Helzner, E., Glymour, M. M. et al., APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology 2008, 70, 1842-1849.
69. Blacker, D., Wilcox, M. A., Laird, N. M., Rodes, L. et al., Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 1998, 19, 357-360.
70. Harold, D., Abraham, R., Hollingworth, P., Sims, R. et al., Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 2009, 41, 1088-1093.
71. Lambert, J. C., Heath, S., Even, G., Campion, D. et al., Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 2009, 41, 1094-1099.
72. Schrijvers, E. M., Koudstaal, P. J., Hofman, A., Breteler, M. M., Plasma clusterin and the risk of Alzheimer disease. JAMA 2011, 305, 1322-1326.
73. Larvie, M., Shoup, T., Chang, W. C., Chigweshe, L. et al., Mannose-binding lectin binds to amyloid beta protein and modulates inflammation. J. Biomed. Biotechnol. 2012, 2012, 929803 [Epub ahead of print].
74. Lanzrein, A. S., Jobst, K. A., Thiel, S., Jensenius, J. C. et al., Mannan-binding lectin in human serum, cerebrospinal fluid and brain tissue and its role in Alzheimer's disease. Neuroreport 1998, 9, 1491-1495.
75. Kahn, C. R., Medicine. can we nip obesity in its vascular bud? Science 2008, 322, 542-543.
76. Wajchenberg, B. L., Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 2000, 21, 697-738.
77. Gesta, S., Tseng, Y. H., Kahn, C. R., Developmental origin of fat: tracking obesity to its source. Cell 2007, 131, 242-256.
78. Ibrahim, M. M., Subcutaneous and visceral adipose tissue: structural and functional differences. Obesity Rev.: Official J. Internat. Assoc. Study of Obesity 2010, 11, 11-18.
79. Sackmann-Sala, L., Berryman, D. E., Lubbers, E. R., Vesel, C. B. et al., Decreased insulin sensitivity and increased oxidative damage in wasting adipose tissue depots of wild-type mice. Age (Dordr) 2012, 34, 1225-1237.
80. Sackmann-Sala, L., Berryman, D. E., Munn, R. D., Lubbers, E. R., Kopchick, J. J., Heterogeneity among white adipose tissue depots in male C57BL/6J mice. Obesity (Silver Spring) 2012, 20, 101-111.
81. Tchkonia, T., Morbeck, D. E., Von Zglinicki, T., Van Deursen, J. et al., Fat tissue, aging, and cellular senescence. Aging cell 2010, 9, 667-684.
82. Villen, J., Beausoleil, S. A., Gerber, S. A., Gygi, S. P., Large-scale phosphorylation analysis of mouse liver. Proc. Natl. Acad. Sci. USA 2007, 104, 1488-1493.
83. Ghesquiere, B., Van Damme, J., Martens, L., Vandekerckhove, J. et al., Proteome-wide characterization of N-glycosylation events by diagonal chromatography. J. Proteome Res. 2006, 5, 2438-2447.
84. Ramella, N. A., Rimoldi, O. J., Prieto, E. D., Schinella, G. R. et al., Human apolipoprotein A-I-derived amyloid: its association with atherosclerosis. PLoS One 2011, 6, e22532.
85. Teoh, C. L., Griffin, M. D., Howlett, G. J., Apolipoproteins and amyloid fibril formation in atherosclerosis. Protein Cell 2011, 2, 116-127.
86. UniProt Consortium, Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res. 2012, 40, D71-D75.
87. Coulson, R. A., Herbert, J. D., A role for carbonic anhydrase in intermediary metabolism. Ann. N. Y. Acad. Sci. 1984, 429, 505-515.
88. Herbert, J. D., Coulson, R. A., A role for carbonic anhydrase in de novo fatty acid synthesis in liver. Ann. N. Y. Acad. Sci. 1984, 429, 525-527.
89. Masternak, M. M., Al-Regaiey, K. A., Del Rosario Lim, M. M., Jimenez-Ortega, V. et al., Effects of caloric restriction on insulin pathway gene expression in the skeletal muscle and liver of normal and long-lived GHR-KO mice. Exp. Gerontol. 2005, 40, 679-684.
90. Ding, J., A Proteomic Approach to Identify Biomarkers for Growth Hormone and Aging, Ph.D. Dissertation, Department of Biological Sciences, Ohio University, 2009.